Aspen Shares Nosedive 15% on JSE After Shock Profit Warning
Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?
Clicks Value Reaches New Heights in Retail Sector
Discover the impressive rise of Clicks value as it nears R100 billion, outpacing Dis-Chem in market valuation.
Netcare on track to meet revenue guidance despite challenges
Netcare, revenue growth, occupancy rates, CEO Richard Friedland, share buyback, South African healthcare